Review of Updated Efficacy and Safety Data from the EMPOWER-CSCC-1 Trial

Dr Hanna comments on updated efficacy and safety data of the EMPOWER-CSCC-1 trial that was recently discussed at the annual ESMO and ASCO 2022 meetings.

Related Videos
Related Content